SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 174.67 |
| Enterprise Value ($M) | 171.35 |
| Book Value ($M) | -5.88 |
| Book Value / Share | -0.21 |
| Price / Book | -29.71 |
| NCAV ($M) | -9.31 |
| NCAV / Share | -0.34 |
| Price / NCAV | -18.77 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.05 |
| Return on Assets (ROA) | -0.21 |
| Return on Equity (ROE) | -4.79 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.97 |
| Current Ratio | 5.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 42.98 |
| Assets | 46.40 |
| Liabilities | 52.28 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 47.54 |
| Operating Income | 2.57 |
| Net Income | -0.07 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 26.98 |
| Cash from Investing | 0.00 |
| Cash from Financing | -13.62 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Solas Capital Management, LLC | 8.20 | ||
| 13G/A | DG Capital Management, LLC | 4.10 | -26.77 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 9,779 | 47,758 | 20.48 | |
| 11,496 | 76,989 | 14.93 | |
| 12,652 | 68,280 | 18.53 | |
| 11,412 | 38,896 | 29.34 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FBIO – Fortress Biotech, Inc. | FBLG – FibroBiologics, Inc. |
| FBRX – Forte Biosciences, Inc. | FLGC – Flora Growth Corp. |
| FTLF – FitLife Brands, Inc. |
Financial data and stock pages provided by
Fintel.io